Jaime Masjuan, MD, PhD, from The Hospital Universitario Ramón y Cajal, Madrid, Spain, outlines the current approaches to stroke prevention in patients with atrial fibrillation. Anticoagulant drugs are the primary treatment provided to prevent ischemic stroke; however breakthrough strokes can still occur in some patients with atrial fibrillation. Dr Masjuan highlights occlusion of the left atrial appendage as a technique to reduce the risk of thrombus formation. There are several ongoing trials to determine if this is a feasible approach moving forward to treat patients who are not compatible with anticoagulant drug therapies, aiming to validate both long-term safety and efficacy. This interview took place at the 10th European Stroke Organisation Conference (ESOC) 2024 in Basel, Switzerland.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
